SAFETY ASSESSMENT OF INHALANT DRUGS AND DERMAL ROUTE DRUGS (English)
- New search for: Gad, Shayne Cox
- New search for: Sullivan, Dexter Jr.
- New search for: Gad, Shayne Cox
- New search for: Sullivan, Dexter Jr.
In:
Drug Safety Evaluation
;
507-527
;
2023
-
ISBN:
- Article/Chapter (Book) / Electronic Resource
-
Title:SAFETY ASSESSMENT OF INHALANT DRUGS AND DERMAL ROUTE DRUGS
-
Contributors:Gad, Shayne Cox ( author ) / Sullivan, Dexter Jr. ( author )
-
Published in:Drug Safety Evaluation ; 507-527
-
Publisher:
- New search for: John Wiley & Sons, Inc.
-
Place of publication:Hoboken, NJ, USA
-
Publication date:2023-01-12
-
Size:21 pages
-
ISBN:
-
DOI:
-
Type of media:Article/Chapter (Book)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents eBook
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
THE DRUG DEVELOPMENT PROCESS AND THE GLOBAL PHARMACEUTICAL MARKETPLACEGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 19
-
REGULATION OF HUMAN PHARMACEUTICAL SAFETY: ROUTES TO HUMAN USE AND MARKETGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 67
-
DATA MINING: SOURCES OF INFORMATION FOR CONSIDERATION IN STUDY AND PROGRAM DESIGN AND IN SAFETY EVALUATIONGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 75
-
ELECTRONIC RECORDS, REPORTING, AND SUBMISSION: eCTD AND SENDGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 83
-
SCREENS IN SAFETY AND HAZARD ASSESSMENTGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 95
-
FORMULATIONS, ROUTES, AND DOSAGE REGIMENSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 131
-
MECHANISMS AND END POINTS OF DRUG TOXICITYGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 143
-
PILOT TOXICITY TESTING IN DRUG SAFETY EVALUATION: MTD AND DRFGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 173
-
REPEAT‐DOSE TOXICITY STUDIESGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 183
-
GENOTOXICITYGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 223
-
QSAR TOOLS FOR DRUG SAFETYGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 241
-
TOXICOGENOMICSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 247
-
IMMUNOTOXICOLOGY IN DRUG DEVELOPMENTGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 293
-
NONRODENT ANIMAL STUDIESGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 331
-
DEVELOPMENTAL AND REPRODUCTIVE TOXICITY TESTINGGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 363
-
CARCINOGENICITY STUDIESGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 395
-
HISTOPATHOLOGY AND CLINICAL PATHOLOGY IN NONCLINICAL PHARMACEUTICAL SAFETY ASSESSMENTGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 403
-
IRRITATION AND LOCAL TISSUE TOLERANCE IN PHARMACEUTICAL SAFETY ASSESSMENTGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 425
-
PHARMACOKINETICS AND TOXICOKINETICS IN DRUG SAFETY EVALUATIONGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 457
-
SAFETY PHARMACOLOGYGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 477
-
SPECIAL CONCERNS FOR THE PRECLINICAL EVALUATION OF BIOTECHNOLOGY PRODUCTSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 507
-
SAFETY ASSESSMENT OF INHALANT DRUGS AND DERMAL ROUTE DRUGSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 529
-
SPECIAL CASE PRODUCTS: IMAGING AGENTSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 535
-
SPECIAL CASE PRODUCTS: DRUGS FOR TREATMENT OF CANCERGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 543
-
PEDIATRIC PRODUCT SAFETY ASSESSMENT (2006 GUIDANCE, INCLUDING JUVENILE AND PEDIATRIC TOXICOLOGY)Gad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 551
-
USE OF IMAGING, IMAGING AGENTS, AND RADIOPHARMACEUTICALS IN NONCLINICAL TOXICOLOGYGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 571
-
OCCUPATIONAL TOXICOLOGY IN THE PHARMACEUTICAL INDUSTRYGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 585
-
STRATEGY AND PHASING FOR NONCLINICAL DRUG SAFETY EVALUATION IN THE DISCOVERY AND DEVELOPMENT OF PHARMACEUTICALSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 603
-
THE APPLICATION OF IN VITRO TECHNIQUES IN DRUG SAFETY ASSESSMENTGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 635
-
EVALUATION OF HUMAN TOLERANCE AND SAFETY IN CLINICAL TRIALS: PHASE I AND BEYONDGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 683
-
POSTMARKETING SAFETY EVALUATION: MONITORING, ASSESSING, AND REPORTING OF ADVERSE DRUG RESPONSES ( ADRs )Gad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 707
-
STATISTICS IN PHARMACEUTICAL SAFETY ASSESSMENTGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 767
-
COMBINATION PRODUCTS: DRUGS AND DEVICESGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 777
-
QUALIFICATION OF IMPURITIES, DEGRADANTS, RESIDUAL SOLVENTS, METALS, AND LEACHABLES IN PHARMACEUTICALSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 789
-
TISSUE, CELL, AND GENE THERAPYGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 801
-
ADVERSE OUTCOME PATHWAYS IN DRUG SAFETY ASSESSMENTGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 805
-
SELECTED REGULATORY AND TOXICOLOGICAL ACRONYMSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 807
-
DEFINITION OF TERMS AND LEXICON OF “CLINICAL” OBSERVATIONS IN NONCLINICAL (ANIMAL) STUDIESGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 811
-
NOTABLE REGULATORY INTERNET ADDRESSESGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 817
-
GLOSSARY OF TERMS USED IN THE CLINICAL EVALUATION OF THERAPEUTIC AGENTSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 821
-
COMMON VEHICLES FOR THE NONCLINICAL EVALUATION OF THERAPEUTIC AGENTSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 919
-
GLOBAL DIRECTORY OF CONTRACT TOXICOLOGY LABSGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- 945
-
INDEXGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023
- i
-
Front MatterGad, Shayne Cox / Sullivan, Dexter Jr. et al. | 2023